EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE-STAGE CKD

被引：0
|
作者：
Hattanda, Fumihiko [1 ]
Makita, Minoru [1 ]
Takeda, Sayo [1 ]
Watanabe, Kanako [1 ]
Kawashima, Keisuke [1 ]
Kondo, Keiichi [1 ]
Ishikawa, Yozou [1 ]
Kusunoki, Yoshihiro [1 ]
Ishikawa, Yasunobu [1 ]
Nishio, Saori [1 ]
Atsumi, Tatsuya [1 ]
机构：
[1] Hokkaido Univ, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP013
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [31] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    DRUGS, 2019, 79 (03) : 303 - 313
  • [32] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [33] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Drugs, 2019, 79 : 303 - 313
  • [34] An update on tolvaptan for autosomal dominant polycystic kidney disease
    Poch, E.
    Rodas, L.
    Blasco, M.
    Molina, A.
    Quintana, L.
    DRUGS OF TODAY, 2018, 54 (09) : 519 - 533
  • [35] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2015, 75 (15) : 1797 - 1806
  • [36] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Tomoyuki Kawada
    Clinical and Experimental Nephrology, 2016, 20 : 147 - 148
  • [37] Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
    Pfeferman, Mariana Becker
    da Rocha, Daniel Ribeiro
    Rodrigues, Fernanda Guedes
    Pfeferman, Elcio
    Heilberg, Ita Pfeferman
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [38] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENT CHARACTERISTICS ASSOCIATED WITH BETTER RESPONSE TO TOLVAPTAN TREATMENT
    Gkika, Vasiliki
    Evangelou, Eirini
    Gkalitsiou, Dimitra
    Liaveri, Paraskevi
    Louka, Michaela
    Drakopoulos, Angelos
    Tigka, Eirini
    Vasileiou, Kyriaki
    Tsagkatakis, Mihail
    Tsirpanlis, George
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I235 - I236
  • [39] Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial
    Torres, Vicente E.
    Higashihara, Eiji
    Devuyst, Olivier
    Chapman, Arlene B.
    Gansevoort, Ronald T.
    Grantham, Jared J.
    Perrone, Ronald D.
    Ouyang, John
    Blais, Jaime D.
    Czerwiec, Frank S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (05): : 803 - 811
  • [40] Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)
    Makabe, Shiho
    Mochizuki, Toshio
    Mitobe, Michihiro
    Aoyama, Yumi
    Kataoka, Hiroshi
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (05) : 1079 - 1087
12345